glp-1 agonists drugs Receptor Agonists: The New Wave in Diabetes Management Hype Or Hope? Latest Research
Description
doi: 10.1016/S0167-0115(02)00157-X [DOI] [PubMed] [Google Scholar] 31.Bodnaruc AM, Prudhomme D, Blanchet R, et al
Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis
Risk of orthostatic hypotension associated with sodium-glucose cotransporter-2 inhibitor treatment: a meta-analysis of randomized controlled trials
The adverse events associated with GLP-1 RA use are generally mild and include nausea and vomiting
10.1016/j.celrep.2014.10.032 16 Da SilvaR
